Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development (Q39379035)

11 September 2017

title

Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development (English)

1 reference

11 September 2017

1 reference

Kaijie Wu

1

1 reference

11 September 2017

Jin Zeng

2

1 reference

11 September 2017

Jiancheng Zhou

3

1 reference

11 September 2017

Jinhai Fan

4

1 reference

11 September 2017

Yule Chen

5

1 reference

11 September 2017

Zhiqiang Wang

6

1 reference

11 September 2017

TingTing Zhang

7

1 reference

11 September 2017

Xinyang Wang

8

1 reference

11 September 2017

Dalin He

9

1 reference

11 September 2017

publication date

14 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

31

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

1751-1760

1 reference

The present and future burden of urinary bladder cancer in the world

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Cadherin switching and bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Cadherin switching dictates the biology of transitional cell carcinoma of the bladder:ex vivo andin vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Epithelial-mesenchymal transitions in development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Biomarkers for epithelial-mesenchymal transitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Transcriptional regulation of cell polarity in EMT and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Unraveling signalling cascades for the Snail family of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Sonic and desert hedgehog signaling in human fetal prostate development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Expression of E-cadherin transcriptional regulators in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

SNAI2/Slug promotes growth and invasion in human gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Function of the zinc-finger transcription factor SNAI2 in cancer and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

The epithelial-mesenchymal transition generates cells with properties of stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Expression of transcription factors snail, slug, and twist in human bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.02.001

10.1016/J.UROLONC.2012.02.001

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference